Atenolol Market Report 2024: Growing Demand for Beta-1 Selective Blockers, Regulatory Approvals for New Formulations and Rising Demand for Combination Therapies in Treating Cardiovascular ...
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
The atenolol market size has grown strongly in recent years, from $11.05 billion in 2023 to $12.01 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historic period can be attributed to several factors, including increased demand and consumption of antihypertensive drugs, a larger patient pool with conditions such as arrhythmia and angina, a rise in the prevalence of glaucoma and arrhythmia, and an increase in the popularity of online pharmacies. The atenolol market size is expected to see strong growth in the next few years. It will grow to $15.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The expected growth in the forecast period can be attributed to several factors, including the increasing demand for atenolol, a growing prevalence of hypertension, heightened awareness of the complexities related to hypertension, a significant rise in the aging population, and poor lifestyle and dietary habits leading to cardiovasc
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Multi-sponsor Pregnancy Exposure Registries: Physician, Scientific Advisory and Industry Insights, Upcoming Webinar Hosted by XtalksPR Web
- Teva Pharmaceutical Industries Limited (NYSE:TEVA) is favoured by institutional owners who hold 68% of the company [Yahoo! Finance]Yahoo! Finance
- Teva to Present at the Bank of America 2024 Global Healthcare ConferenceGlobeNewswire
- Medincell Mandates ROTHSCHILD MARTIN MAUREL to Manage Its Liquidity Contract [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
TEVA
Earnings
- 7/31/24 - Beat
TEVA
Sec Filings
- 9/4/24 - Form 4
- 8/14/24 - Form 144/A
- 8/14/24 - Form 144/A
- TEVA's page on the SEC website